Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Drive18h
The small cars that consume the most fuel
Among the small cars tested across the AAA’s six rounds, the Toyota Corolla performed the best, with a 2022 Corolla drinking ...
Dawn18h
Call for ending graft to attract investment
ISLAMABAD: A visiting IMF mission on Friday called on the president of the Supreme Court Bar Association (SCBA) and chairman ...
TipRanks on MSN19h
Safran SA Reports Strong Financial Growth in 2024
Safran Sa Unsponsored Adr ( ($SAFRY) ) has released its Q4 earnings. Here is a breakdown of the information Safran Sa Unsponsored Adr presented to ...
TipRanks on MSN19h
Hermès International Reports Strong 2024 Earnings Growth
Hermes International SCA Unsponsored ADR ( ($HESAY) ) has released its Q4 earnings. Here is a breakdown of the information Hermes International ...
Zeekr Group Announces the Closing of Strategic Integrated Transactions
ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group ...